Michael D. Staehler, MD (he/him/his)

University of Munich

Michael Staehler MD, PhD, Profesoor of Urology, Dept of Urology, University of Munich

Michael Staehler is the founder and head of the Interdisciplinary Center for Renal Tumours at Ludwig-Maximilians University of Munich, Munich, Germany. It is the first multi-disciplinary cancer center for renal neoplasms in Germany certified by the German Cancer Society (DKG). Professor Staehler is also Head of the Urological Oncology Service for Advanced Genitourinary Cancer and Kidney Surgery. He is vice chairman of the Department of Urology of the University of Munich. He heads the interdisciplinary tumor board on genitourinary cancer at the Comprehensive Cancer Center of the University of Munich.

Professor Staehler’s main research interest has been the development of novel therapeutics in RCC, particularly in the area of surgical therapy, novel targeted agents and radiation therapy. He is co-founder of the Tuberous Sclerosis Centre at LMU. He is past president of the German Society for Immune and Targeted Therapy and Member of the Renal Cancer Workgroup of the German Cancer Society. He also serves as a member of the German Guideline Committee on Renal Cancer and Renal Cancer Guideline Committee on Renal Cancer of the European Association of Urology. He also is a Medical Advisor to the German Kidney Cancer Association. He serves on the editorial board of several journals, has published more than 250 articles on renal cancer and is a co-author of several textbooks

Disclosure information not submitted.

Presentation(s):

• PD15-10: Long term follow up in patients undergoing renal biopsy - seeding is not anecdotal

  Friday, May 13, 2022
  5:00 PM – 5:10 PM

• PD18-11: First In-Human Results of ⁶⁸Ga-EMP-100 PET for Imaging c-MET Expression in Renal Cell Carcinoma

  Saturday, May 14, 2022
  8:40 AM – 8:50 AM

• V10: Adrenal & Renal Oncology I

  Sunday, May 15, 2022
  3:30 PM – 5:30 PM